Aura Biosciences, Inc. (AURA)
6.74
+0.11
(+1.66%)
USD |
NASDAQ |
Apr 08, 15:40
Aura Biosciences Shareholders Equity (Quarterly) : 136.91M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 93.95M |
| Olema Pharmaceuticals, Inc. | 478.56M |
| Elicio Therapeutics, Inc. | 1.636M |
| ACADIA Pharmaceuticals, Inc. | 1.227B |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 319.98M |
| Total Liabilities (Quarterly) | 183.06M |
| Debt to Equity Ratio | 0.1269 |
| Current Ratio | 8.146 |
| Net Debt Paydown Yield | 0.10% |